Search

Your search keyword '"Swarup S"' showing total 66 results

Search Constraints

Start Over You searched for: Author "Swarup S" Remove constraint Author: "Swarup S" Publisher elsevier bv Remove constraint Publisher: elsevier bv
66 results on '"Swarup S"'

Search Results

13. Rates of RNFL Thinning in Patients with Suspected or Confirmed Glaucoma Receiving Unilateral Intravitreal Injections for Exudative AMD

14. Role of Caspase-1 as a Biomarker of Ocular Surface Damage

16. Study Spark Gap of Wire Electric Discharge Machining on AISI 4140

17. Hot Embossing of polymers – A review

21. Predictors of Neovascular Glaucoma in Central Retinal Vein Occlusion

22. Concurrent acute retinal necrosis and orbital inflammation: Report of 2 cases

23. Optimization of Process Parameters of Wire Electric Discharge Machining on AISI 4140 Using Taguchi Method and Grey Relational Analysis

24. Review on Single and Multi-objective Optimization Process Parameters of EDM Using Taguchi Method and Grey Relational Analysis

32. Reply to Kumawat and associates

33. Treatment-related adverse events and tolerability in patients with advanced non-squamous non-small cell lung cancer treated with first-line checkpoint inhibitors in combination with chemotherapy

34. Combination therapy with checkpoint inhibitors for first-line treatment of advanced renal cell carcinoma: A systematic review and meta-analysis of randomized controlled trials

35. Treatment-related adverse events and tolerability in patients with advanced renal cell carcinoma treated with first-line combination therapy with checkpoint inhibitors

36. MA03.07 First-Line Atezolizumab Chemoimmunotherapy in Advanced Non-Squamous NSCLC Patients Harboring EGFR/ALK Genetic Alterations

37. Atezolizumab in combination with chemotherapy for first-line treatment of advanced non-small cell lung cancer: A systematic review and meta-analysis of randomized controlled trials (RCTs)

38. P1.01-78 Treatment-Related Adverse Events in Patients with Advanced NSCLC Treated with First-Line Atezolizumab Chemoimmunotherapy

39. P2.04-09 Immune-Related Adverse Events in Advanced Non-Squamous NSCLC Patients Treated with Upfront Checkpoint Inhibitors Combination

40. Upfront atezolizumab chemoimmunotherapy-associated immune-related adverse events in patients with advanced non-small cell lung cancer

41. EP1.01-10 Pembrolizumab in Combination with Chemotherapy as First-Line Treatment of Advanced Non-Small Cell Lung Cancer

42. P2.04-46 Tolerability and Treatment-Related Adverse Events of Upfront Pembrolizumab Combination Regimens in Advanced NSCLC Patients

43. P2.04-86 Efficacy of Ipilimumab in Combination with Chemotherapy for First-Line Treatment of Advanced Lung Cancer

44. P1.04-78 Efficacy of Checkpoint Inhibitors in Combination with Chemotherapy for First-Line Treatment of Advanced Non-Squamous NSCLC

50. Implementation and Comparison of Speech Emotion Recognition System Using Gaussian Mixture Model (GMM) and K- Nearest Neighbor (K-NN) Techniques

Catalog

Books, media, physical & digital resources